DLB - Dolby Laboratories, Inc.
NYSE
->
Technology
->
Information Technology Services
San Francisco,
United States
Type: Equity
DLB price evolution
DLB
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $778.62 | $824.36 | $708.66 | |
| Short term investments | $127.32 | $115.86 | $140.82 | |
| Net receivables | $476.65 | $525.3 | $510.79 | |
| Inventory | $34.72 | $35.8 | $37.57 | |
| Total current assets | $1468.65 | $1551.74 | $1451.36 | |
| Long term investments | $117.9 | $127.97 | $92.88 | |
| Property, plant & equipment | $517.54 | $524.55 | $517.32 | |
| Goodwill & intangible assets | $553.1 | $560.8 | $570.33 | |
| Total noncurrent assets | $1504.98 | $1492.99 | $1484.17 | |
| Total investments | $245.22 | $243.84 | $233.7 | |
| Total assets | $2973.64 | $3044.73 | $2935.53 | |
| Current liabilities | ||||
| Accounts payable | $297.02 | $382.61 | $341.58 | |
| Deferred revenue | $32.65 | $37.7 | $33.4 | |
| Short long term debt | $12.57 | $14.21 | $12.92 | |
| Total current liabilities | $354.54 | $442.9 | $394.1 | |
| Long term debt | $35.62 | $37.71 | $34.32 | |
| Total noncurrent liabilities | $171.67 | $164.14 | $179.12 | |
| Total debt | $48.19 | $51.92 | $47.24 | |
| Total liabilities | $526.2 | $607.04 | $573.22 | |
| Shareholders' equity | ||||
| Retained earnings | $2462.93 | $2449.88 | $2367.18 | |
| Other shareholder equity | -$30.17 | -$29.07 | -$21.43 | |
| Total shareholder equity | $2432.85 | $2420.9 | $2345.85 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $817.97 | $628.37 | $1233.03 | $1079.98 |
| Short term investments | $139.15 | $189.21 | $38.84 | $46.95 |
| Net receivables | $444.38 | $419.69 | $414.93 | $180.34 |
| Inventory | $35.62 | $23.55 | $10.96 | $25.55 |
| Total current assets | $1487.8 | $1310.89 | $1760.5 | $1547.2 |
| Long term investments | $97.81 | $102.51 | $62.82 | $52.15 |
| Property, plant & equipment | $521.78 | $560.01 | $601.51 | $618.48 |
| Goodwill & intangible assets | $575.84 | $477.41 | $463.58 | $489.38 |
| Total noncurrent assets | $1491.96 | $1378.65 | $1345.19 | $1370.13 |
| Total investments | $236.96 | $291.73 | $101.66 | $99.1 |
| Total assets | $2979.77 | $2689.55 | $3105.69 | $2917.32 |
| Current liabilities | ||||
| Accounts payable | $372.32 | $244.41 | $280.51 | $232.59 |
| Deferred revenue | $31.5 | $18.59 | $18.47 | $15.44 |
| Short long term debt | $13.63 | $13.26 | $15.4 | $15.82 |
| Total current liabilities | $422.23 | $277.52 | $315.72 | $267.11 |
| Long term debt | $37.02 | $37.69 | $56.72 | $65.31 |
| Total noncurrent liabilities | $185.36 | $161.01 | $185.74 | $211.81 |
| Total debt | $50.65 | $50.94 | $72.12 | $81.14 |
| Total liabilities | $607.58 | $438.53 | $501.45 | $478.92 |
| Shareholders' equity | ||||
| Retained earnings | $2391.99 | $2297.73 | $2607.91 | $2443.14 |
| Other shareholder equity | -$36.98 | -$51.64 | -$10.03 | -$10.59 |
| Total shareholder equity | $2355.1 | $2246.18 | $2597.98 | $2432.64 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $364.52 | $315.57 | ||
| Cost of revenue | $38.78 | $32.06 | ||
| Gross Profit | $325.75 | $283.51 | ||
| Operating activities | ||||
| Research & development | $62.49 | $67.03 | ||
| Selling, general & administrative | $156.78 | $144.17 | ||
| Total operating expenses | $216.78 | $217.29 | ||
| Operating income | $108.97 | $66.22 | ||
| Income from continuing operations | ||||
| EBIT | $112.77 | $71.05 | ||
| Income tax expense | $23.53 | $13.25 | ||
| Interest expense | -$8.6 | -$9.19 | ||
| Net income | ||||
| Net income | $97.83 | $66.98 | ||
| Income (for common shares) | $97.83 | $66.98 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1299.74 | $1253.79 | $1281.26 | $1161.79 |
| Cost of revenue | $152.57 | $141.36 | $130.03 | $146.5 |
| Gross Profit | $1147.18 | $1112.43 | $1151.23 | $1015.29 |
| Operating activities | ||||
| Research & development | $271.52 | $261.17 | $253.64 | $239.04 |
| Selling, general & administrative | $612.84 | $634.03 | $556.83 | $555.69 |
| Total operating expenses | $931.42 | $905.83 | $806.84 | $796.55 |
| Operating income | $215.75 | $206.6 | $344.39 | $218.74 |
| Income from continuing operations | ||||
| EBIT | $220.98 | $215.86 | $347.39 | $239.65 |
| Income tax expense | $48.41 | $31.38 | $36.69 | $8.1 |
| Interest expense | -$28.09 | $0.39 | $0.48 | $0.19 |
| Net income | ||||
| Net income | $200.66 | $184.09 | $310.23 | $231.36 |
| Income (for common shares) | $200.66 | $184.09 | $310.23 | $231.36 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | $38.44 | $97.83 | $66.98 | $9.19 |
| Operating activities | ||||
| Depreciation | $21.21 | $20.78 | $20.96 | $24.26 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $29.34 | $28.91 | $31.89 | $28.2 |
| Total cash flows from operations | $21.26 | $181.41 | $8.41 | $85.02 |
| Investing activities | ||||
| Capital expenditures | -$7.61 | -$8.92 | -$6.1 | -$8.19 |
| Investments | -$0.13 | -$8.96 | $6.73 | -$11.53 |
| Total cash flows from investing | -$7.74 | -$17.87 | $0.63 | -$19.71 |
| Financing activities | ||||
| Dividends paid | -$28.7 | -$28.72 | -$28.55 | -$25.82 |
| Sale and purchase of stock | -$26.23 | -$15.45 | -$96.26 | -$16.98 |
| Net borrowings | ||||
| Total cash flows from financing | -$58.4 | -$44.16 | -$125.14 | -$42.8 |
| Effect of exchange rate | -$0.86 | -$3.68 | $6.79 | -$3.7 |
| Change in cash and equivalents | -$45.73 | $115.7 | -$109.31 | $18.81 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $200.66 | $184.09 | $310.23 | $231.36 |
| Operating activities | ||||
| Depreciation | $95.51 | $103.61 | $112.76 | $90.88 |
| Business acquisitions & disposals | $25.7 | -$38.17 | -$4.5 | |
| Stock-based compensation | $118.49 | $114.92 | $99.7 | $86.63 |
| Total cash flows from operations | $367.08 | $318.58 | $447.75 | $343.85 |
| Investing activities | ||||
| Capital expenditures | -$30.34 | -$59.46 | -$38.09 | -$66.35 |
| Investments | $58.84 | -$198.31 | -$2.32 | $203.36 |
| Total cash flows from investing | $54.21 | -$295.94 | -$44.91 | $134.37 |
| Financing activities | ||||
| Dividends paid | -$103.41 | -$100.07 | -$89.17 | -$88.58 |
| Sale and purchase of stock | -$132.64 | -$509.06 | -$155.98 | -$114.15 |
| Net borrowings | ||||
| Total cash flows from financing | -$236.81 | -$610.56 | -$252.51 | -$207.78 |
| Effect of exchange rate | $5.12 | -$16.74 | $2.72 | $3.94 |
| Change in cash and equivalents | $189.59 | -$604.66 | $153.05 | $274.39 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.26 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |